Retreatment efficacy and predictors of ledipasvir plus sofosbuvir to HCV genotype 1 in Japan.
Akuta N, Sezaki H, Suzuki F, Fujiyama S, Kawamura Y, Hosaka T, Kobayashi M, Kobayashi M, Saitoh S, Suzuki Y, Arase Y, Ikeda K, Kumada H.
Akuta N, et al. Among authors: fujiyama s.
J Med Virol. 2017 Feb;89(2):284-290. doi: 10.1002/jmv.24617. Epub 2016 Jul 6.
J Med Virol. 2017.
PMID: 27357737